Клиническое значение копептина и матриксных металлопротеиназ у мужчин с острым коронарным синдромом
Аннотация
Об авторах
О. С. ТананаРоссия
И. А. Сукманова
Россия
И. В. Пономаренко
Россия
Список литературы
1. O'Donoghue M.L., Morrow D.A., Cannon C.P., Jarolim P., Desai N.R., Sherwood M.W. et al. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction. J Am Heart Assoc. 2016; 5 (5). DOI: 10.1161/JAHA.115.002586.
2. Sinning C., Ojeda F., Zeller T., Zengin E., Rupprecht H.-J., Lackner K.-. et al. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress. Can J Cardiol. 2016; 32 (12): 1470-7. DOI: 10.1016/j.cjca.2016.05.010.
3. Kip M.M., Steuten L.M., Koffijberg H., IJzerman M.J., Kusters R. Using expert elicitation to estimate the potential impact of improved diagnostic performance of laboratory tests: a case study on rapid discharge of suspected non-ST elevation myocardial infarction patients. J Eval Clin Pract. 2016; DOI: 10.1111/jep.12626.
4. Ahmad T., Wang T., O'Brien E.C., Samsky M.D., Pura J.A., Lokhnygina Y. et al. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. JACC Heart Fail. 2015; 3 (1): 30-9. DOI: 10.1016/j.jchf.2014.06.013.
5. Mueller M., Giannitsis E., Katus H.A. [Essential cardiac biomarkers in myocardial infarction and heart failure]. Herz. 2014; 39 (6): 727-739; quiz 740-741. DOI: 10.1007/s00059-014-4136-8.
6. Thelin J., Melander O., Öhlin B. Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T. Eur Heart J Acute Cardiovasc Care. 2015; 4 (5): 403-9. DOI: 10.1177/2048872614554107.
7. Sörensen N.A., Shah A.S., Ojeda F.M., Peitsmeyer P., Zeller T., Keller T. et al. High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibrillation. Eur Heart J Acute Cardiovasc Care. 2016; 5 (6): 419-27. DOI: 10.1177/2048872615611108.
8. Vafaie M., Slagman A., Möckel M., Hamm C., Huber K., Müller C. et al. Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome. Am J Med. 2016; 129 (3): 274-282.e2. DOI: 10.1016/j.amjmed.2015.10.016.
9. Smaradottir M.I., Ritsinger V., Gyberg V., Norhammar A., Näsman P., Mellbin L.G. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort. Diab Vasc Dis Res. 2017; 14 (2): 69-76. DOI: 10.1177/1479164116664490.
10. Tasevska I., Enhörning S., Persson M., Nilsson P.M., Melander O. Copeptin predicts coronary artery disease cardiovascular and total mortality. Heart. 2016; 102 (2): 127-32. DOI: 10.1136/heartjnl-2015-308183.
11. Searle J., Slagman A., Stockburger M., Vollert J.O., Müller C., Muller R. et al. Use of copeptin in emergency patients with cardiac chief complaints. Eur Heart J Acute Cardiovasc Care. 2015; 4 (5): 393-402. DOI: 10.1177/2048872614554197.
12. Jacobs L.H.J., van Borren M., Gemen E., van Eck M., van Son B., Glatz J.F.C. et al. Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin. Ann Clin Biochem. 2015; 52 (Pt 5): 550-61. DOI: 10.1177/0004563215578189.
13. Savic-Radojevic A., Pljesa-Ercegovac M., Matic M., Simic D., Radovanovic S, Simic T. Novel Biomarkers of Heart Failure. Adv Clin Chem. 2017; 79: 93-152. DOI: 10.1016/bs.acc.2016.09.002.
14. Stallone F., Schoenenberger A.W., Puelacher C., Rubini Gimenez M., Walz B., Naduvilekoot Devasia A. et al. Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset. Eur Heart J Acute Cardiovasc Care. 2016; 5 (5): 407-15. DOI: 10.1177/2048872616641289.
15. Hamed G.M., Fattah M.F.A. Clinical Relevance of matrix metallopro-teinase 9 in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2015; 21 (8): 705-11. DOI: 10.1177/1076029614567309.
Рецензия
Для цитирования:
Танана О.С., Сукманова И.А., Пономаренко И.В. Клиническое значение копептина и матриксных металлопротеиназ у мужчин с острым коронарным синдромом. Кардиология. 2017;57(3S):32-39. https://doi.org/10.18087/cardio.2400
For citation:
Tanana O.S., Sukmanova I.A., Ponomarenko I.V. The clinical significance of copeptin and matrix metalloproteinases in men with acute coronary syndrome. Kardiologiia. 2017;57(3S):32-39. (In Russ.) https://doi.org/10.18087/cardio.2400